from Dreamers to Disruptors

In life sciences, everything is connected. Local solutions can have global impacts, and broad approaches are often modified in fascinating ways to address unique healthcare challenges. Through our NEXT Innovation Series, Medidata explores how these interacting trends drive transformation in cities and regions across the world.

At NEXT Shanghai, we shone the spotlight on China’s healthcare industry across a series of special from Dreamers to Disruptors sessions. Recorded live from the show floor, Medidatians and NEXT guests explored the implementation of AI in Asia and beyond, and how Medidata’s partnerships are building a new era of clinical intelligence.

Session 1 Speakers:

• Anthony Costello, CEO, Medidata
• Dr. Zhongmin (Max) Wang, Co-founder & Senior Vice President, Akeso Biopharma

Session 2 Speakers:

• Aryana Hosseinkhani, VP, Head of Product Marketing, Medidata
• Nik Morton, EVP and Chief Strategy & Transformation Officer, Worldwide Clinical Trials
• Megan Collett, Executive Director, APAC Operations Oncology, Worldwide Clinical Trials
• Lisa Moneymaker, Chief Operating & Strategy Officer, Medidata

Session 3 Speakers:

• Jeff Ventimiglia, SVP, Operations & Transformation, Medidata
• Wayne Walker, General Manager, Head of Data Experience, Medidata

Session 4 Speakers:

• Krystal Cao, Solution Sales Consultant, Medidata
• Mingfei Sun, Solutions Consultant, Medidata

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

AI tools are saving lives. With a level of pattern recognition that no human could ever hope to match, they can identify the hidden signs that indicate life-threatening complications, and empower healthcare professionals to take action before things escalate.

But a tool is only effective if it’s put to use, and in many cases adoption is slow and far from widespread. Bayesian Health CEO and Co-Founder Dr. Suchi Saria is accelerating the process, drawing on her experiences at Johns Hopkins to develop AI-powered solutions that have become deeply embedded in the day-to-day practices of major healthcare institutions.

She joins Medidata CEO Anthony Costello for a wide-ranging conversation that explores Bayesian’s human-machine teaming approach to developing new technologies, and the future of interconnected health data that is just on the horizon.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Anthony: LinkedIn

Follow Suchi: LinkedIn

A cancer diagnosis is one of the most challenging experiences a person can have. As well as the physical consequences of serious illness, people can find themselves feeling isolated as they struggle with fear and uncertainty about what lies ahead.

By founding Man Up to Cancer, Trevor Maxwell is giving people the confidence and community they need to confront diagnosis, treatment, and the day-to-day reality of living with the disease. He joins Medidata’s Chief Patient Officer Alicia Staley to share his experience with colon cancer, and his amazing journey to become a patient advocate.

They explore the problems of toxic positivity and lack of motivation, the relationship between clinical research and cancer communities, and how to use your skills and knowledge to make a positive difference for yourself and those around you.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Alicia: LinkedIn

Follow Trevor: LinkedIn

New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation.

As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies.

He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Anthony: LinkedIn

Follow Craig: LinkedIn

At its heart, Medidata NEXT is a conversation where leading experts in clinical research come together in open dialogue. Representing the biggest names in healthcare and life sciences from around the world, they explore industry challenges and share their excitement for what the future holds.

That made NEXT Innovation Day London the perfect venue for our latest live edition of from Dreamers to Disruptors. Recorded straight from the show floor, Medidata leaders and a broad range of guests break down the power and incredible potential of AI across the clinical trial process, combining diverse perspectives into a united vision for the next era of healthcare technology.

Session 1 Speakers:

• Edward Ford | Vice President, Client Engagement, Medidata
• Anthony Costello | CEO, Medidata
• Nitish Mittal | Partner, Everest Group
• Krzysztof Wróblewski | Head of Global Clinical Solutions Technologies, Senior Director, AstraZeneca

Session 2 Speakers:

• Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata
• Lisa Moneymaker | Chief Strategy Officer, Medidata
• Chris Standley | Vice President, Vendor Governance, Worldwide Clinical Trials

Session 3 Speakers:

• Wayne Walker | GM, Head of Data Experience, Medidata
• Robyn Orie | Sr. Director, Data Innovation, Caidya
• Cassie Kendrew | Chief Operating Officer, EMS Healthcare
• Amardeep Heer | Medidata Site Insights Board Member | Principal Investigator, Lakeside Healthcare

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

External Control Arms are a powerful clinical research tool, harnessing cutting-edge tech to fill gaps in clinical data and accelerate trials when patients’ lives are on the line. They’re particularly valuable for cancer research, where patients can neither afford to wait nor settle for the current standard of care.

Friends of Cancer Research President and CEO Jeff Allen sits down with Medidata CEO Anthony Costello and Senior Vice President, Statistics and Regulatory Science Innovation Ruthie Davi to celebrate 30 years of oncology innovation, and explore what’s coming next.

They dig deep into Medidata and Friends’ partnership to bring the power of External Control Arms to pancreatic cancer research, and how to build a future where clinical research takes full advantage of these life-saving innovations.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Anthony: LinkedIn

Follow Jeff: LinkedIn

Follow Ruthie: LinkedIn

NEXT New York is our flagship event, bringing together the world’s leading life sciences companies and thinkers to envision a transformative future for healthcare that challenges our preconceptions of what’s possible in clinical trials.

This special edition of from Dreamers to Disruptors was recorded live from the show floor at NEXT, capturing the hottest takes and insights from Medidata leaders and special guests. From the end-to-end AI support reshaping studies, to building trust in cutting-edge clinical technologies, our speakers share their fresh perspectives on what matters most to pharma professionals today.

Session 1 Speakers:

• Edward Ford | Vice President, Client Engagement, Medidata
• Anthony Costello | CEO, Medidata
• Matteo di Tommaso | Senior Vice President, R&D Business Insights & Technology, Bristol Myers Squibb
• Nimita Limaye | Research Vice President, Life Sciences R&D Strategy and Technology, IDC

Session 2 Speakers:

• Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata
• Meghan Harrington | Vice President, Clinical Trial Financial Management, Medidata
• Paul O'Donohoe | Senior Director, eCOA Product and Science, Medidata
• Sharlene Carnegie | Senior Vice President, Product and Engineering, Medidata

Session 3 Speakers:

• Jeff Ventimiglia | Senior Vice President, Offering and Portfolio Management, Medidata
• Bryant Fields | Vice President, Partnerships, Medidata
• Robert Lyons | Vice President, Engineering, Medidata
• Jia Chen | Head, Product, AI, Medidata

Session 4 Speakers:

• Lisa Moneymaker | Senior Vice President, Chief Strategy Officer, Medidata
• Tom Doyle | Senior Vice President, Chief Technology Officer, Medidata
• Claire Biot | Vice President, Life Sciences and Healthcare Industry, Dassault Systèmes
• Patrick Johnson | EVP, Corporate Research and Sciences, Dassault Systèmes

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

As a veteran entrepreneur in life sciences, Lee Shapiro has invested in some of the most transformative technologies in modern healthcare history—developing a deep understanding of what makes for truly successful innovation.

Medidata CEO Anthony Costello sits down with Lee to discover the secret to his success. Charting his work across a variety of leading life sciences organizations, from Allscripts and Livongo, to Click Therapeutics and Medidata itself, Lee uncovers the qualities that underpin the most accomplished enterprises.

Join Lee and Anthony as they paint a powerful picture of our evolving industry and explore the disruptions shaping the future of healthcare.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Anthony: LinkedIn

Follow Lee: LinkedIn

As we enter the new year, the mandate is clear: evolve clinical research or get left behind.

Join us to revisit conversations between Medidata CEO Anthony Costello and some of the leading industry minds—including Every Cure’s David Fajgenbaum, Digital Medicine Society’s Jennifer Goldsack, and Click Therapeutics’ David Klein—as they look to the future of life sciences in 2026 and beyond.

From unlocking deeper data insights to scaling radical innovation, our guests issue a direct call to action: harness today’s cutting-edge technology to build a faster, smarter, and healthier world for patients everywhere.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Anthony: LinkedIn

David Fajgenbaum’s relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Castleman disease and running out of treatment options, David used his research skills to identify an existing drug that saved his life.

Join David and Medidata CEO Anthony Costello to explore the origins of Every Cure—and how David’s experience became the seed for a nonprofit that uncovers life-changing uses for treatments already approved for other conditions. Discover Every Cure’s innovative approaches to data, the scope of unmet needs across healthcare, and how pharmaceutical companies can contribute to a future where we unlock the full potential of treatments for all.

Visit our website

Read our blog

Follow Medidata: LinkedIn, Instagram, X, YouTube

Follow Anthony: LinkedIn

Follow David: LinkedIn